| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |